Real world efficacy and safety of teriflunomide in multiple sclerosis: an observational study with four years follow-up
Bildiriler > Özet Bildiri · 2019
Yazarlar: CAVİT BOZ, M. Terzi, S. Ozakbas, Ayşe Nur YÜCEYAR, HÜSNÜ EFENDİ, B. P. Balci, R. Turkoglu, RANA KARABUDAK, A. Soysal, MEHMET FATİH YETKİN, A. Kurne, A. Akcali, G. Akman, M. Demirkiran, S. Sevim, N. Kiyioglu, V. Cilingir, M. Koseoglu, G. Uzuner, S. Omerhoca, O. F. Turan, F. Kizilay
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, İsveç, Uluslararası, Sözlü Sunum, Özet Bildiri, 2019-2019, Wos, cilt 25, ss 870-870